These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6720682)

  • 1. Increased prevalence of polycythemia vera in parents of patients on polycythemia vera study group protocols.
    Brubaker LH; Wasserman LR; Goldberg JD; Pisciotta AV; McIntyre OR; Kaplan ME; Modan B; Flannery J; Harp R
    Am J Hematol; 1984 May; 16(4):367-73. PubMed ID: 6720682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989.
    Anía BJ; Suman VJ; Sobell JL; Codd MB; Silverstein MN; Melton LJ
    Am J Hematol; 1994 Oct; 47(2):89-93. PubMed ID: 8092146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosis.
    Ruggeri M; Tosetto A; Frezzato M; Rodeghiero F
    Ann Intern Med; 2003 Sep; 139(6):470-5. PubMed ID: 13679323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of molecular testing to identify a cluster of patients with polycythemia vera in eastern Pennsylvania.
    Seaman V; Jumaan A; Yanni E; Lewis B; Neyer J; Roda P; Xu M; Hoffman R
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):534-40. PubMed ID: 19190168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inapparent polycythemia vera: an unrecognized diagnosis.
    Lamy T; Devillers A; Bernard M; Moisan A; Grulois I; Drenou B; Amiot L; Fauchet R; Le Prise PY
    Am J Med; 1997 Jan; 102(1):14-20. PubMed ID: 9209196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial polycythemia vera.
    Miller RL; Purvis JD; Weick JK
    Cleve Clin J Med; 1989; 56(8):813-8. PubMed ID: 2691118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycythemia Vera.
    Spivak JL
    Curr Treat Options Oncol; 2018 Mar; 19(2):12. PubMed ID: 29516275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of polycythemia vera in a defined population.
    Berglund S; Zettervall O
    Eur J Haematol; 1992 Jan; 48(1):20-6. PubMed ID: 1730276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic studies in polycythemia vera.
    Jarosová M; Indrák K; Dusek J; Kapustová M
    Neoplasma; 1988; 35(2):221-8. PubMed ID: 3374710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and treatment of polycythemia vera patients in clinical practice: a multicenter chart review on 1476 individuals in Germany.
    Jentsch-Ullrich K; Eberhardt J; Zeremski V; Koehler M; Wolleschak D; Heidel FH
    J Cancer Res Clin Oncol; 2016 Sep; 142(9):2041-9. PubMed ID: 27431664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Familial polyglobulism--a rare differential diagnosis of polycythemia vera].
    Klingler KW; Lengfelder E; Kohne E; Arnold H
    Med Klin (Munich); 1988 May; 83(11):363-6. PubMed ID: 3405151
    [No Abstract]   [Full Text] [Related]  

  • 12. Symptomatic splenomegaly in polycythemia vera: a review of the indications for splenectomy and perioperative considerations.
    Logan MS; Watson CM; Nottingham JM
    Am Surg; 2009 May; 75(5):363-8. PubMed ID: 19445284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polycythemia vera].
    Rain JD
    Rev Prat; 2002 Oct; 52(16):1801-7. PubMed ID: 12564173
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of polycythemia vera and essential thrombocythemia.
    Ma X; Vanasse G; Cartmel B; Wang Y; Selinger HA
    Am J Hematol; 2008 May; 83(5):359-62. PubMed ID: 18181200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia.
    Michiels JJ; Berneman Z; Schroyens W; van Urk H
    Ann Hematol; 2003 Mar; 82(3):153-9. PubMed ID: 12634947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAK2V617F mutational frequency in polycythemia vera: 100%, >90%, less?
    Verstovsek S; Silver RT; Cross NC; Tefferi A
    Leukemia; 2006 Nov; 20(11):2067. PubMed ID: 16990780
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
    Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A note on the increased risk of polycythemia vera in Jews.
    Modan B; Kallner H; Zemer D; Yoran C
    Blood; 1971 Feb; 37(2):172-6. PubMed ID: 5549194
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythropoietin radioimmunoassay in evaluating patients with polycythemia.
    Koeffler HP; Goldwasser E
    Ann Intern Med; 1981 Jan; 94(1):44-7. PubMed ID: 7447223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAK2 exon 12 mutated polycythemia vera: Mayo-Careggi MPN Alliance study of 33 consecutive cases and comparison with JAK2V617F mutated disease.
    Tefferi A; Lavu S; Mudireddy M; Lasho TL; Finke CM; Gangat N; Pardanani A; Hanson CA; Mannarelli C; Guglielmelli P; Vannucchi AM
    Am J Hematol; 2018 Aug; 93(4):E93-E96. PubMed ID: 29274140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.